Imatinib mesylate blocks a non-Smad TGF-β pathway and reduces renal fibrogenesis in vivo

Shinong Wang, Mark C. Wilkes, Edward B. Leof, Raimund Hirschberg

Research output: Contribution to journalArticlepeer-review

213 Scopus citations

Fingerprint Dive into the research topics of 'Imatinib mesylate blocks a non-Smad TGF-β pathway and reduces renal fibrogenesis in vivo'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences

Agriculture & Biology